$MIST
Milestone Pharmaceuticals Inc.
Nasdaq · Healthcare · Pharmaceutical Preparations · Montreal, Quebec, Canada
MIST chart
What traders are saying about $MIST
Latest postsMilestone Pharmaceuticals Inc. news
- Weekly Recap: Third-quarter results and CARDAMYST AHA presentation
TradingView ·
- Milestone Pharmaceuticals Inc. (MIST) Seasonal Returns Chart - Yahoo Finance
Yahoo! Finance Canada ·
- MIST Q3'26 Earnings: revenue estimate is 1.00M USD
TradingView ·
- New data demonstrate etripamil nasal spray can convert recurrent PSVT to normal heart rhythm in prior-ablation patients
Cardiac Rhythm News ·
- Milestone Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Yahoo Finance ·
- Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
Yahoo Finance ·
- New Data Presented at AHA Scientific Sessions 2026 Demonstrate That CARDAMYST® (etripamil) Nasal Spray Converted Recurrent PSVT to Normal Heart Rhythm in Patients with Prior Catheter Ablation
Yahoo Finance ·
- Milestone Pharmaceuticals (MIST) Stock Sees Fair Value Falls As Analysts Reset Cardamyst Expectations
Yahoo Finance ·
- Milestone Pharmaceuticals Announces Clinical Data Presentations at Upcoming Cardiology Conferences
Yahoo Finance ·
- Milestone Pharmaceuticals Announces First European Study Participant Enrolled in ReVeRA-301 Phase 3 Clinical Trial
Yahoo Finance ·
- Milestone Pharmaceuticals Enrolls First Canadian Study Participant in ReVeRA-301 Phase 3 Pivotal Trial Evaluating Etripamil Nasal Spray for AFib-RVR
Yahoo Finance ·
- Milestone Pharmaceuticals Announces NMPA Approval of Etripamil Nasal Spray for PSVT in China, Marking First Regulatory Approval of Etripamil Outside of the United States
Yahoo Finance ·
Milestone Pharmaceuticals Inc. key financials
| USD | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|
| Net income | -$63,058 | -$41,519 | -$59,685 | -$58.4M |
| Diluted EPS | $-0.75 | $-0.67 | $-1.39 | $-1.38 |
| Total assets (year end) | $113.6M | $75.5M | $75.2M | $74.5M |
| Cash and equivalents (year end) | $73.0M | $25.3M | $13.8M | $7.6M |
Calendar-year figures as reported to the SEC in XBRL filings.
Recent SEC filings
About Milestone Pharmaceuticals Inc.
- Ticker
- MIST (Nasdaq)
- Industry
- Pharmaceutical Preparations
- Headquarters
- Montreal, Quebec, Canada
- Incorporated in
- Quebec, Canada
- Fiscal year end
- December 31
- SEC CIK
- 1408443
Frequently asked questions
What exchange is Milestone Pharmaceuticals Inc. listed on?
Milestone Pharmaceuticals Inc. trades on the Nasdaq under the ticker symbol MIST.
What industry is Milestone Pharmaceuticals Inc. in?
Milestone Pharmaceuticals Inc. is classified by the SEC under "Pharmaceutical Preparations", part of the Healthcare sector on StockTweeting.
Where is Milestone Pharmaceuticals Inc. headquartered?
Milestone Pharmaceuticals Inc.'s business address on file with the SEC is in Montreal, Quebec, Canada.
When does Milestone Pharmaceuticals Inc.'s fiscal year end?
Milestone Pharmaceuticals Inc.'s fiscal year ends on December 31.